Access to Quality Care: Access to skilled surgeons and effective antibiotics significantly improves survival chances
A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared with Placebo and Open-Label Liraglutide in Patients with Type 2 Diabetes
doi:10.1152/japplphysiol.00141.2010 Baguet, A., Everaert, I., Hespel, P., Petrovic, M., Achten, E., & Derave, W
Effects of SGLT2 Inhibitors on Cardiovascular Outcomes and Mortality in Type 2 Diabetes: A Meta-Analysis
Retrieved from gov/articlerender.fcgi?artid=3698662&tool=pmcentrez&renderty pe=abstract 62
It works by increasing satiety, reducing appetite, and moderating blood sugar fluctuations, similar to the other GLP-1s, but generally with milder effects